Discover our current projects and also our closed projects.
For more information, please use the Contact Us form, indicating the category "Other" and clearly stating "EU Projects".
The ESC is involved in a number of EU funded research projects, often as a dissemination partner. Our role is fundamental to ensure the very latest scientific best practice is shared with as many cardiovascular practitioners, researchers and institutions as possible.
Discover our current projects and also our closed projects.
For more information, please use the Contact Us form, indicating the category "Other" and clearly stating "EU Projects".
Next generation tools for genome-centric multimodal data integration in personalised cardiovascular medicine
Start date: January 2024
End date: December 2028
Trustworthy
artificial intelligence for personalised risk assessment in chronic heart
failure
Start date: June 2023
End date: May 2027
A European health
data toolbox for enhancing cardiology data interoperability, reusability and
privacy
Start date: October 2022
End date: September 2026
Remote ischemic conditioning in lymphoma patients receiving anthracyclines
Start date: June 2021
End date: May 2026
Addressing
multimorbidity in elderly atrial fibrillation patients through
interdisciplinary, tailored, patient-centered care pathways.
Start date: April 2021
End date: March 2026
An innovative
solution for treating elderly breast cancer patients at risk for cardiotoxicity
Start date: January 2021
End date: June
2025
Personalized
prevention for coronary heart disease
Start date: January 2020
End date: December 2026
A high-dimensional
approach for unwinding immune-metabolic causes of cardiovascular
disease-depression multimorbidities
Start date: January 2020
End date: December 2024
Prevention of sudden
cardiac death after myocardial infarction by defibrillator implantation
Start date: January 2020
End date: December 2024
Paraplegia prevention
in aortic aneurysm repair by thoracoabdominal staging with ‘minimally-invasive
segmental artery coil-embolization’
Start date: January 2017
End date: September 2024
Improved methods for clinical investigation and evaluation of high-risk medical devices
Start date: April 2021
End date: March 2024
Digital, risk-based screening for atrial fibrillation in the European community
Start date: April 2021
End date: March
2024
An EU-Canada joint infrastructure for next-generation multi-Study Heart research
Start date: December 2018
End date: May 2023
Big Data 4 Better Hearts
Start date: March 2017
End date: February 2023
European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment
Start date: January 2017
End date: December 2022
A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease
Start date: May 2015
End date: August 2022
Our mission: To reduce the burden of cardiovascular disease.